Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats

References

• UNODC. Early warning advisory on new psychoactive substances. [cited 2017 Mar 4]. Available from: https://www.unodc.org/LSS/Home/NPS.
   Google Scholar
• EMCDDA. Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl) pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV) in the framework of the Council Decision on new psychoactive substances. [cited 2014 Oct 22]. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_228256_EN_TDAK14003ENN.pdf.
   Google Scholar
• EMCDDA. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). [cited 2015 Apr 23]. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_235958_EN_TD0415135 ENN.pdf.
   Google Scholar
• Busardò FP, Kyriakou C, Napoletano S, et al. Mephedrone related fatalities: a review. Eur Rev Med Pharmacol Sci. 2015;19:3777–3790.
   PubMed Web of Science ®Google Scholar
• Meltzer PC, Butler D, Deschamps JR, et al. 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors. J Med Chem. 2006;49:1420–1432.
   PubMed Web of Science ®Google Scholar
• Gardos G, Cole JO. Evaluation of pyrovalerone in chronically fatigued volunteers. Curr Ther Res Clin Exp. 1971;13:631–635.
   PubMed Web of Science ®Google Scholar
• Fung M, Thornton A, Mybeck K, et al. Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets – 1960 to 1999. Drug Inf J. 2001;35:293–317.
   Web of Science ®Google Scholar
• WHO Convention on psychotropicsubstances 1971. [cited 2016 Mar 4]. Available from: https://www.unodc.org/pdf/convention_1971_en.pdf.
   Google Scholar
• Lindeman E, Hulten P, Ström S, et al. Increased abuse of the Internet drug MDPV in Västmanland. Severe cases of poisoning have given health care major problems. Läkartidningen. 2012;109:1954–1957.
   PubMedGoogle Scholar
• Kankaanpää A, Ariniemi K, Heinonen M, et al. Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities. Sci Total Environ. 2014;487:696–702.
   PubMed Web of Science ®Google Scholar
• Coppola M, Mondola R. 3,4-Methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett. 2012;208:12–15.
   PubMed Web of Science ®Google Scholar
• Beck O, Franzen L, Bäckberg M, et al. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project. Clin Toxicol. 2015;53:865–873.
   PubMed Web of Science ®Google Scholar
• EMCDDA-Europol. Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). EMCDDA, Europol, 2016. [cited 2016 Nov 30]. Available from: http://www.emcdda.europa.eu/system/files/publi-cations/2934/TDAK16001ENN.pdf.
   Google Scholar
• Gatch MB, Dolan SB, Forster MJ. Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives. J Pharmacol Exp Ther. 2015;354:103–110.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Antonazzo KR, Wiley JL, et al. Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014;87:206–213.
   PubMed Web of Science ®Google Scholar
• Rickli A, Hoener MC, Liechti ME. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones. Eur Neuropsychopharmacol. 2015;25:365–376.
   PubMed Web of Science ®Google Scholar
• Kolanos R, Sakloth F, Jain AD, et al. Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters. ACS Chem Neurosci. 2015;6:1726–1731.
   PubMed Web of Science ®Google Scholar
• Beck O, Franzén L, Bäckberg M, et al. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol. 2016;54:568–575.
   PubMed Web of Science ®Google Scholar
• Lindeman E, Feychting K. [MDPV: new drug of abuse that has come to stay?]. Läkartidningen. 2015;112:982.
   Google Scholar
• Helander A, Beck O, Hägerkvist R, et al. Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project. Scand J Clin Lab Investig. 2013;73:400–406.
   PubMed Web of Science ®Google Scholar
• Helander A, Bäckberg M, Hultén P, et al. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int. 2014;243:23–29.
   PubMed Web of Science ®Google Scholar
• Bäckberg M, Lindeman E, Beck O, et al. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol. 2015;53:46–53.
   PubMed Web of Science ®Google Scholar
• Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine - experience from the Swedish population. J Chromatogr B. 2013;930:112–120.
   PubMed Web of Science ®Google Scholar
• Stephanson NN, Signell P, Helander A, et al. Use of LC–HRMS in full scan-XIC mode for multi-analyte urine drug testing – a step towards a “black-box” solution? J Mass Spectrom. 2017;52:497–506.
   PubMed Web of Science ®Google Scholar
• Helander A, Bäckberg M. New psychoactive substances (NPS) – the hydra monster of recreational drugs. Clin Toxicol. 2017;55:1–3.
   PubMed Web of Science ®Google Scholar
• Cheong JH, Choi MJ, Jang CG, et al. Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents. Psychopharmacology. 2017;234:857–867.
   PubMed Web of Science ®Google Scholar
• Eshleman AJ, Wolfrum KM, Reed JF, et al. Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. J Pharmacol Exp Ther. 2017;360:33–47.
   PubMed Web of Science ®Google Scholar
• Wojcieszak J, Andrzejczak D, Woldan-Tambor A, et al. Cytotoxic activity of pyrovalerone derivatives, an emerging group of psychostimulant designer cathinones. Neurotox Res. 2016;30:239–250.
   PubMed Web of Science ®Google Scholar